Internal Medicine, Nephrology · Miami, FL
NPI
1154522852
Since 2007
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
7900 S.W. 57 Avenue #21
Miami, FL, 33143
Phone (305) 662-3984
Groups this clinician bills Medicare through
Medicare paid, 2024
$217K
2,063 services
Medicare patients, 2024
668
Average age 76
Drug cost, 2024
$629K
1,341 prescriptions
Company payments, 2025
$1,637
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose B Esquenazi was code 99232 (hospital e&m - subsequent), 846 times for 339 patients. In total Jose B Esquenazi billed 2,063 services in 18 codes, and Medicare paid $217K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-09-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 846 | 339 | $65.30 | $55K |
| 99222 Hospital E&M - Initial | Facility | 333 | 286 | $109.40 | $36K |
| 99214 Office E&M - Established | Office | 309 | 153 | $65.97 | $20K |
| 90960 ESRD Related Services (not dialysis) | Office | 200 | 33 | $290.88 | $58K |
| 99233 Hospital E&M - Subsequent | Facility | 81 | 42 | $96.77 | $7,838 |
| 99213 Office E&M - Established | Office | 71 | 53 | $62.48 | $4,436 |
| 90935 Hemodialysis | Facility | 53 | 36 | $58.61 | $3,106 |
| 90961 ESRD Related Services (not dialysis) | Office | 49 | 21 | $242.08 | $12K |
| 99223 Hospital E&M - Initial | Facility | 24 | 24 | $144.80 | $3,475 |
| 99204 Office E&M - New | Office | 21 | 21 | $130.69 | $2,745 |
By year: 2022 $239K for 2,370 services; 2023 $235K for 2,129 services; 2024 $217K for 2,063 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 18 | 16 | $2.98 | $53.7 |
Medicare prescription drug claims, 2024
In 2024, the drug Jose B Esquenazi prescribed most often to Medicare patients was Lokelma (Sodium Zirconium Cyclosilicate), with 171 prescriptions and refills. In total Jose B Esquenazi wrote 1,341 Medicare prescriptions that cost $629K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lokelma Sodium Zirconium Cyclosilicate | 171 | 201 | 32 | $158K |
| Veltassa Patiromer Calcium Sorbitex | 119 | 135 | 32 | $138K |
| Losartan Potassium Generic | 114 | 309 | 46 | $875 |
| Nifedipine Er Nifedipine | 103 | 283 | 48 | $3,174 |
| Velphoro Sucroferric Oxyhydroxide | 70 | 72 | 15 | $158K |
| Farxiga Dapagliflozin Propanediol | 70 | 130 | 24 | $71K |
| Hydralazine Hcl Generic | 67 | 177 | 26 | $731 |
| Furosemide Generic | 62 | 175 | 25 | $297 |
| Sevelamer Carbonate Generic | 58 | 120 | 18 | $8,551 |
| Amlodipine Besylate Generic | 57 | 157 | 29 | $350 |
| Carvedilol Generic | 37 | 94 | 13 | $203 |
| Lisinopril Generic | 32 | 93 | 12 | $162 |
| Bumetanide Generic | 27 | 64 | 11 | $871 |
| Prednisone Generic | 23 | 55 | Under 11 | $101 |
| Cefdinir Generic | 21 | 21 | 20 | $316 |
Brand drugs: 499 claims; generic drugs: 842 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose B Esquenazi $1,637 ($1,637 in general payments such as food, travel and fees) from 14 companies. The largest payer was GlaxoSmithKline, LLC. with $212.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 5 | $212 |
| Amgen Inc. AMGN | 8 | $181 |
| Ardelyx, Inc. ARDX | 9 | $177 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $166 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $163 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $156 |
| Aurinia Pharma U.S., Inc. AUPH | 6 | $144 |
| Novo Nordisk Inc NVO | 5 | $119 |
| Fresenius USA Marketing, Inc. | 4 | $82.21 |
| Travere Therapeutics, Inc. TVTX | 3 | $81.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.